Both in Biotechnology
Outlook Therapeutics vs LENZ Therapeutics
Over the past year OTLK returned −62.8% and LENZ returned −89.7%; their daily moves had a correlation of 0.12.
OTLK −62.8% LENZ −89.7%Growth of $1, one year, split-adjusted
| Metric | OTLK | LENZ |
|---|---|---|
| Price | $0.4681 | $3.05 |
| Market cap | $114.0M | $95.8M |
| Today | −5.15% | −12.61% |
| 1 month | −18.6% | −19.5% |
| 6 months | +78.5% | −65.7% |
| Year to date | −70.4% | −80.9% |
| 1 year | −63.4% | −90.0% |
| Revenue growth (YoY) | −99.4% | +9.7% |
| Gross margin | −95.0% | 94.9% |
| Net margin | −233554.9% | −581.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 4.5× |
| Net cash | -$7.0M | $220.0M |
| Dividend yield | — | — |
| Volatility (60d) | 93.9% | 70.2% |
| Short % of float | 39.3% | 46.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).